Credit Suisse’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $23.3M | Sell |
169,161
-31,020
| -15% | -$4.28M | 0.02% | 587 |
|
|
2023
Q4 | $26.4M | Sell |
200,181
-32,664
| -14% | -$4.3M | 0.03% | 577 |
|
|
2023
Q3 | $26.2M | Sell |
232,845
-7,639
| -3% | -$859K | 0.03% | 566 |
|
|
2023
Q2 | $22.7M | Sell |
240,484
-24,944
| -9% | -$2.35M | 0.02% | 618 |
|
|
2023
Q1 | $26.9M | Buy |
265,428
+58,512
| +28% | +$5.92M | 0.03% | 573 |
|
|
2022
Q4 | $24.7M | Sell |
206,916
-104
| -0.1% | -$12.4K | 0.03% | 597 |
|
|
2022
Q3 | $22M | Buy |
207,020
+39,561
| +24% | +$4.2M | 0.02% | 623 |
|
|
2022
Q2 | $16.3M | Sell |
167,459
-3,109
| -2% | -$303K | 0.02% | 746 |
|
|
2022
Q1 | $16M | Sell |
170,568
-10,433
| -6% | -$978K | 0.01% | 845 |
|
|
2021
Q4 | $15.4M | Buy |
181,001
+41,585
| +30% | +$3.54M | 0.01% | 897 |
|
|
2021
Q3 | $13.4M | Buy |
139,416
+12,715
| +10% | +$1.22M | 0.01% | 986 |
|
|
2021
Q2 | $12.3M | Buy |
126,701
+17,305
| +16% | +$1.68M | 0.01% | 1040 |
|
|
2021
Q1 | $10.6M | Buy |
109,396
+907
| +0.8% | +$88.2K | 0.01% | 1148 |
|
|
2020
Q4 | $10.4M | Sell |
108,489
-640
| -0.6% | -$61.3K | 0.01% | 1103 |
|
|
2020
Q3 | $10.5M | Buy |
109,129
+1,281
| +1% | +$123K | 0.01% | 972 |
|
|
2020
Q2 | $13.2M | Buy |
107,848
+3,972
| +4% | +$485K | 0.01% | 891 |
|
|
2020
Q1 | $8.99M | Sell |
103,876
-34,961
| -25% | -$3.03M | 0.01% | 951 |
|
|
2019
Q4 | $14.9M | Buy |
138,837
+19,747
| +17% | +$2.12M | 0.01% | 900 |
|
|
2019
Q3 | $10.7M | Buy |
119,090
+45,344
| +61% | +$4.09M | 0.01% | 951 |
|
|
2019
Q2 | $6.23M | Sell |
73,746
-1,798
| -2% | -$152K | 0.01% | 1212 |
|
|
2019
Q1 | $6.66M | Sell |
75,544
-340,815
| -82% | -$30M | 0.01% | 1159 |
|
|
2018
Q4 | $29.7M | Buy |
416,359
+100,569
| +32% | +$7.18M | 0.03% | 474 |
|
|
2018
Q3 | $38.8M | Buy |
315,790
+29,742
| +10% | +$3.66M | 0.03% | 439 |
|
|
2018
Q2 | $28.1M | Sell |
286,048
-171,321
| -37% | -$16.8M | 0.03% | 550 |
|
|
2018
Q1 | $37.9M | Buy |
457,369
+130,933
| +40% | +$10.9M | 0.04% | 459 |
|
|
2017
Q4 | $25.3M | Buy |
326,436
+89,320
| +38% | +$6.93M | 0.02% | 612 |
|
|
2017
Q3 | $14.5M | Sell |
237,116
-20,030
| -8% | -$1.23M | 0.01% | 828 |
|
|
2017
Q2 | $11.8M | Sell |
257,146
-71,199
| -22% | -$3.27M | 0.01% | 923 |
|
|
2017
Q1 | $14.2M | Buy |
328,345
+90,741
| +38% | +$3.93M | 0.01% | 878 |
|
|
2016
Q4 | $9.2M | Sell |
237,604
-13,021
| -5% | -$504K | 0.01% | 1076 |
|
|
2016
Q3 | $12.7M | Sell |
250,625
-69,781
| -22% | -$3.53M | 0.01% | 924 |
|
|
2016
Q2 | $14.6M | Buy |
320,406
+19,047
| +6% | +$866K | 0.02% | 838 |
|
|
2016
Q1 | $11.9M | Buy |
301,359
+27,931
| +10% | +$1.1M | 0.01% | 921 |
|
|
2015
Q4 | $15.5M | Buy |
273,428
+22,678
| +9% | +$1.28M | 0.02% | 853 |
|
|
2015
Q3 | $9.98M | Sell |
250,750
-80,779
| -24% | -$3.21M | 0.01% | 1044 |
|
|
2015
Q2 | $15.8M | Buy |
331,529
+43,750
| +15% | +$2.09M | 0.02% | 878 |
|
|
2015
Q1 | $11.4M | Buy |
287,779
+34,566
| +14% | +$1.37M | 0.01% | 1011 |
|
|
2014
Q4 | $5.66M | Buy |
253,213
+25,284
| +11% | +$565K | 0.01% | 1440 |
|
|
2014
Q3 | $3.57M | Buy |
227,929
+51,008
| +29% | +$800K | ﹤0.01% | 1736 |
|
|
2014
Q2 | $2.63M | Sell |
176,921
-61,707
| -26% | -$916K | ﹤0.01% | 2143 |
|
|
2014
Q1 | $3.84M | Buy |
238,628
+24,603
| +11% | +$396K | ﹤0.01% | 1726 |
|
|
2013
Q4 | $2M | Sell |
214,025
-72,203
| -25% | -$674K | ﹤0.01% | 2287 |
|
|
2013
Q3 | $3.24M | Buy |
286,228
+143,988
| +101% | +$1.63M | ﹤0.01% | 1686 |
|
|
2013
Q2 | $1.9M | Buy |
+142,240
| New | +$1.9M | ﹤0.01% | 1984 |
|